2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Chemotherapy
Chemotherapy stands as a cornerstone in the landscape of cancer treatment, continuously evolving through innovative research. This systemic approach utilizes powerful drugs to target and destroy rapidly dividing cancer cells throughout the body. As researchers delve deeper into the complexities of cancer biology, new chemotherapy agents emerge, offering enhanced efficacy with fewer side effects. Moreover, cutting-edge studies explore personalized chemotherapy regimens tailored to individual genetic profiles, maximizing treatment outcomes while minimizing adverse reactions. Beyond conventional chemotherapy, investigations into novel drug delivery systems seek to improve targeting specificity, reducing harm to healthy tissues. With each breakthrough, the frontier of cancer research expands, illuminating pathways towards more effective, tolerable, and personalized chemotherapy interventions, fostering hope for improved patient outcomes in the ongoing fight against cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China